190 related articles for article (PubMed ID: 30711558)
1. Photochemical property of two Ru(II) compounds based on 5-(2-pyrazinyl)tetrazole for cancer phototherapy by changing auxiliary ligand.
Yang J; Xu Y; Jiang M; Zou D; Yang G; Shen L; Zou J
J Inorg Biochem; 2019 Apr; 193():124-129. PubMed ID: 30711558
[TBL] [Abstract][Full Text] [Related]
2. Two photoactive Ru (II) compounds based on tetrazole ligands for photodynamic therapy.
Yang J; He X; Ke Z; Chen J; Zou Z; Wei B; Zou D; Zou J
J Inorg Biochem; 2020 Sep; 210():111127. PubMed ID: 32521288
[TBL] [Abstract][Full Text] [Related]
3. Two Ru(II) compounds with aggregation induced emission as promising photosensitizers for photodynamic therapy.
Xu H; Zhang X; Li X; Zhang X; Deng J; Zou D; Yang J
J Inorg Biochem; 2020 Nov; 212():111233. PubMed ID: 33010531
[TBL] [Abstract][Full Text] [Related]
4. Boosting type I process of Ru(II) compounds by changing tetrazole ligand for enhanced photodynamic therapy against lung cancer.
Zhang X; Huang X; Xie A; Zhang X; Deng J; Zou D; Zou J
J Inorg Biochem; 2020 Nov; 212():111236. PubMed ID: 32889130
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
6. Photoinduced ligand exchange and DNA binding of cis-[Ru(phpy)(phen)(CH3CN)2]+ with long wavelength visible light.
Sears RB; Joyce LE; Ojaimi M; Gallucci JC; Thummel RP; Turro C
J Inorg Biochem; 2013 Apr; 121():77-87. PubMed ID: 23353083
[TBL] [Abstract][Full Text] [Related]
7. Dual-Action Ru(II) Complexes with Bulky π-Expansive Ligands: Phototoxicity without DNA Intercalation.
Toupin NP; Nadella S; Steinke SJ; Turro C; Kodanko JJ
Inorg Chem; 2020 Mar; 59(6):3919-3933. PubMed ID: 32096986
[TBL] [Abstract][Full Text] [Related]
8. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
Li A; Turro C; Kodanko JJ
Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
[TBL] [Abstract][Full Text] [Related]
9. Tuning Polyamidoamine Design To Increase Uptake and Efficacy of Ruthenium Complexes for Photodynamic Therapy.
Mascheroni L; Dozzi MV; Ranucci E; Ferruti P; Francia V; Salvati A; Maggioni D
Inorg Chem; 2019 Nov; 58(21):14586-14599. PubMed ID: 31618015
[TBL] [Abstract][Full Text] [Related]
10. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
11. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
12. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
[TBL] [Abstract][Full Text] [Related]
13. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
[TBL] [Abstract][Full Text] [Related]
14. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
[TBL] [Abstract][Full Text] [Related]
16. Antiparasitic activities of novel ruthenium/lapachol complexes.
Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
[TBL] [Abstract][Full Text] [Related]
17. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
18. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
19. Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes.
Herrera-Ramírez P; Berger SA; Josa D; Aguilà D; Caballero AB; Fontova P; Soto-Cerrato V; Martínez M; Gamez P
J Biol Inorg Chem; 2023 Jun; 28(4):403-420. PubMed ID: 37059909
[TBL] [Abstract][Full Text] [Related]
20. The trans-[Ru(PPh
Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
